Insider Buying Sparks Interest in HBCP
Ballard John Scott purchased 100 shares of HBCP on June 12, 2026, amid active insider trading.
Key Points
- Ballard John Scott bought 100 shares of HBCP on June 12, 2026, highlighting insider interest in the stock.
- HBCP shares traded at $68.08, with significant movement among institutional investors, including Dimensional Fund Advisors and BlackRock.
- Analysts have mixed views, with Piper Sandler recently downgrading the stock to 'hold' with a $69 price target.
Ballard John Scott recently purchased 100 shares of HBCP on June 12, 2026. This insider buying activity comes as part of a series of transactions by company insiders, reflecting ongoing interest in the stock. HBCP shares were trading at $68.08 at the time of these transactions.
Insider Buying and Selling at HBCP
Several insiders, including Ann Forte Trappey, Daniel Guidry, Chris Rader, and Paul Blanchet III, each bought 100 shares of HBCP on June 12, 2026. Meanwhile, Mark Herpin, the SEVP and Chief Operations Officer, sold 110 shares at $68.08 on the same day. These transactions were not part of any pre-arranged trading plans.
Other Institutional Activity in HBCP
Institutional investors have also been active with HBCP shares. Dimensional Fund Advisors LP increased its holdings by 7,792 shares, bringing its total to 429,581 shares valued at about $26.02 million. BlackRock, Inc. reduced its stake by 6,737 shares, leaving it with 411,940 shares worth approximately $24.96 million. American Century Companies Inc added 25,614 shares, totaling 186,588 shares valued at $11.30 million. Vanguard Capital Management LLC initiated a position with 295,778 shares valued at $17.92 million, while Geode Capital Management, LLC grew its holdings by 5,364 shares to 164,365 shares, valued at $9.96 million.
Analysts Set New Price Targets
Analysts have differing opinions on HBCP's outlook. On April 22, 2026, Piper Sandler downgraded the stock to a 'hold' with a $69 price target. Raymond James, however, maintained a 'buy' rating with a $62 target back in July 2025. The consensus among analysts leans towards a 'buy' recommendation, with a mean target price of $69.
Bottom Line
The recent insider and institutional activity in HBCP, along with mixed analyst ratings, suggests a dynamic interest in the stock. Investors often watch such movements for potential insights. However, it's important to remember that insider transactions and 13F filings are backward-looking and may not reflect current positions.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.